Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen
Clinical trial NCT00002429 · COMPLETED
Trial details
- NCT number
- NCT00002429
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-07-01
- Primary completion
- 2001-01-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.